Evotec (EVO) said Wednesday that Chief Financial Officer Laetitia Rouxel will step down, effective Feb. 28, to explore other opportunities.
Paul Hitchin will succeed Rouxel as CFO, effective March 1. Hitchin most recently served as CFO of Mediq.
Evotec shares were down 3.4% in recent premarket activity Wednesday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.